Skip to main content
. 2015 Oct 21;6(35):38225–38238. doi: 10.18632/oncotarget.5425

Table 1. Inhibition of target agents in MCL cell lines.

Drug IC50
Jeko1 Mino Jeko1/BTZ Mino/BTZ
Doxorubicin (μM) 0.703 0.215 0.63 0.21
Vincristine (nM) 0.638 0.631 0.47 0.43
PP2 (μM) 43.516 37.742 15.947 8.745
LY294002 (μM) 15.342 17.854 6.743 8.962
Rapamycin (μM) >5 >5 0.086 0.103

The IC50 value of various anti-cancer agents (BTZ, Doxorubicin, Vincristine, PP2, LY294002, and Rapamycin) for 72 hr treatment of Jeko1, Mino, and BTZ-resistant cells was determined using the MTT assay.